Latest profit margin for Eton Pharmaceuticals: 35.35% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for ETON is 35.35% as of September 2026. That compares with -9.5% in the prior-year period — up 472.0% year over year. That is above the Healthcare sector average of 17.63%. Investors often review this figure alongside Eton Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.
Over the past year, ETON's profit margin moved from -9.5% to 35.35% — a 472.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Eton Pharmaceuticals's valuation or profitability profile.
Against Healthcare companies, ETON currently prints 35.35% for profit margin, while the sector average sits near 17.63%. That is roughly 100.5% above the sector mean. Large gaps often invite a closer look at Eton Pharmaceuticals's growth, margins, and balance sheet.
Profit Margin shows how effectively Eton Pharmaceuticals converts resources into returns. At 35.35%, ETON may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -9.5% in the prior-year period — up 472.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ETON's profit margin (35.35%), review year-over-year change from -9.5%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.